Progression of patterns (POP): a machine classifier algorithm to identify glaucoma progression in visual fields.

Published online

Journal Article

PURPOSE: We evaluated Progression of Patterns (POP) for its ability to identify progression of glaucomatous visual field (VF) defects. METHODS: POP uses variational Bayesian independent component mixture model (VIM), a machine learning classifier (MLC) developed previously. VIM separated Swedish Interactive Thresholding Algorithm (SITA) VFs from a set of 2,085 normal and glaucomatous eyes into nine axes (VF patterns): seven glaucomatous. Stable glaucoma was simulated in a second set of 55 patient eyes with five VFs each, collected within four weeks. A third set of 628 eyes with 4,186 VFs (mean ± SD of 6.7 ± 1.7 VFs over 4.0 ± 1.4 years) was tested for progression. Tested eyes were placed into suspect and glaucoma categories at baseline, based on VFs and disk stereoscopic photographs; a subset of eyes had stereophotographic evidence of progressive glaucomatous optic neuropathy (PGON). Each sequence of fields was projected along seven VIM glaucoma axes. Linear regression (LR) slopes generated from projections onto each axis yielded a degree of confidence (DOC) that there was progression. At 95% specificity, progression cutoffs were established for POP, visual field index (VFI), and mean deviation (MD). Guided progression analysis (GPA) was also compared. RESULTS: POP identified a statistically similar number of eyes (P > 0.05) as progressing compared with VFI, MD, and GPA in suspects (3.8%, 2.7%, 5.6%, and 2.9%, respectively), and more eyes than GPA (P = 0.01) in glaucoma (16.0%, 15.3%, 12.0%, and 7.3%, respectively), and more eyes than GPA (P = 0.05) in PGON eyes (26.3%, 23.7%, 27.6%, and 14.5%, respectively). CONCLUSIONS: POP, with its display of DOC of progression and its identification of progressing VF defect pattern, adds to the information available to the clinician for detecting VF progression.

Full Text

Duke Authors

Cited Authors

  • Goldbaum, MH; Lee, I; Jang, G; Balasubramanian, M; Sample, PA; Weinreb, RN; Liebmann, JM; Girkin, CA; Anderson, DR; Zangwill, LM; Fredette, M-J; Jung, T-P; Medeiros, FA; Bowd, C

Published Date

  • September 25, 2012

Published In

Volume / Issue

  • 53 / 10

Start / End Page

  • 6557 - 6567

PubMed ID

  • 22786913

Pubmed Central ID

  • 22786913

Electronic International Standard Serial Number (EISSN)

  • 1552-5783

Digital Object Identifier (DOI)

  • 10.1167/iovs.11-8363

Language

  • eng

Conference Location

  • United States